News Search Results
Aug 12, 2025, 08:00 ET Diakonos Oncology Expands Leadership Team with Appointment of Donna Rill as Chief Technology Officer
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the appointment of Donna
More news about: Diakonos Oncology
Aug 12, 2025, 08:00 ET Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about
More news about: Avant Technologies Inc.
Aug 12, 2025, 08:00 ET Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update
Aug. 12, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, provides a
More news about: Coya Therapeutics, Inc.
Aug 12, 2025, 08:00 ET 180 Life Sciences (ETHZilla) Holds 82,186 ETH
top-tier DeFi founders, infrastructure pioneers and other ecosystem heavyweights. The Company, originally formed as an innovative biotechnology company, has also been evolving its business towards software enabled gaming and entertainment. In addition to its newly disclosed ETH
More news about: 180 Life Sciences Corp.
Aug 12, 2025, 07:47 ET Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
Aug. 12, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system
More news about: Intensity Therapeutics Inc.
Aug 12, 2025, 07:00 ET Apriori Bio Announces Collaboration with the Francis Crick Institute
CAMBRIDGE, Mass., Aug. 12, 2025 /PRNewswire/ -- Apriori Bio, a biotechnology company focused on developing variant-resilient vaccines, today announced a research collaboration with the Francis Crick Institute to better understand
More news about: Apriori Bio
Aug 12, 2025, 06:00 ET Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology
biotech renowned for its transformative technologies in adeno-associated viruses (AAV) manufacturing and tissue-targeted delivery. KLOTHO is a biotechnology company focused on the development of groundbreaking, disease-modifying cell and gene therapies using a human gene and protein derived from its
More news about: Klotho Neurosciences, Inc.
Aug 11, 2025, 21:36 ET Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million
March 2024. It is a biotechnology company specializing in the research and development of innovative therapies for autoimmune diseases with a core management team of experienced professionals with deep expertise in multinational pharmaceutical and biotechnology companies R&D, business development
More news about: Fosun Pharma
Aug 11, 2025, 16:55 ET Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
matters voted on at the annual meeting will also be filed on SEDAR. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in multiple first-line
More news about: Oncolytics Biotech® Inc.
Aug 11, 2025, 15:22 ET Aquaporin lowers revenue guidance for 2025, but maintains EBITDA guidance, and initiates strategic review
Aquaporin A/S (ticker: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces, pursuant to the Market Abuse Regulation on publication of inside information, that the Company is lowering its revenue guidance
More news about: Aquaporin A/S
Aug 11, 2025, 15:20 ET Aquaporin lowers revenue guidance for 2025, but maintains EBITDA guidance, and initiates strategic review
Aquaporin A/S (ticker: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces, pursuant to the Market Abuse Regulation on publication of inside information, that the Company is lowering its revenue guidance
More news about: Aquaporin A/S
Aug 11, 2025, 12:00 ET The Galien Foundation Announces 2025 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product" and "Best Product for Rare/Orphan Diseases"
dedicated to honoring innovators in life sciences, today announced the 2025 Prix Galien USA Award nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Disease." Winners will be announced during the Prix Galien USA
More news about: The Galien Foundation
Aug 11, 2025, 12:00 ET Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering
Aug. 11, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Harbinger Health, a biotechnology company pioneering the detection of early cancer, today announced the appointment of Ajit Singh, Ph.D. as CEO-Partner
More news about: Flagship Pioneering
Aug 11, 2025, 10:01 ET Next-Generation Solar Cell Market to Soar to US$12.95 Billion by 2031, Driven by Rising Solar Installations and Renewable Energy Investments - The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 11, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Aug 11, 2025, 09:30 ET AGEBOX Presents iKids-Growth: Pioneering Safe and Natural Support for Children's Height Development
This product is not intended to diagnose, treat, cure, or prevent any disease. About AGEBOX AGEBOX Inc. is a U.S.-based biotechnology company that develops evidence-based dietary supplements to support children's growth, cognition, and metabolic health. The company's proprietary
More news about: AGEBOX
Aug 11, 2025, 09:06 ET Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions
With over two decades of expertise, Caliber has helped pharmaceutical and biotechnology companies in 17 countries enhance quality systems, streamline operations, and ensure regulatory compliance. To mark this milestone, Caliber
More news about: Caliber Technologies
Aug 11, 2025, 08:58 ET Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions
With over two decades of expertise, Caliber has helped pharmaceutical and biotechnology companies in 17 countries enhance quality systems, streamline operations, and ensure regulatory compliance. To mark this milestone, Caliber
More news about: Caliber Technologies
Aug 11, 2025, 08:30 ET Enhancing Patient Recruitment in Clinical Research: A Personalized and Engaged Journey, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 11, 2025, 08:05 ET Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)
MEETING, Pa., Aug. 11, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Aug 11, 2025, 08:00 ET 180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes
assets per the terms of the Convertible Notes, and to continue its current iGaming operations, as well as continuing to seek to monetize its legacy biotechnology intellectual property. Advisors Clear Street LLC acted as financial advisor and exclusive placement agent for the Convertible
More news about: 180 Life Sciences Corp.
Aug 11, 2025, 08:00 ET AMI Pharm Advances AYP-101 to Phase 3, Paving the Way for a New Era in Fat-Reduction Injectable drugs
Aug. 11, 2025 /PRNewswire/ -- AMI Pharm, a biotechnology company specializing in next-generation aesthetic solutions, today announced that its lead drug candidate, AYP-101, has entered a pivotal
More news about: AMI Pharm
Aug 11, 2025, 05:19 ET Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion
dedicated to building cutting-edge biotechnology platforms for new protein, new antibody, nucleic acid and other drugs. Adhering to the platform driven development model of "innovation+internationalization", It also explores the extensive application of biotechnology in the big health sector. The strategic
More news about: Kexing Biopharm
Aug 11, 2025, 03:00 ET NaoTrac de Brain Navi Biotechnology realiza las primeras cirugías en España
content:https://www.prnewswire.com/es/comunicados-de-prensa/naotrac-de-brain-navi-biotechnology-realiza-las-primeras-cirugias-en-espana-302524987.html
More news about: Brain Navi Biotechnology Co., Ltd.
Aug 11, 2025, 03:00 ET AMI Pharm Advances AYP-101 to Phase 3, Redefining Fat-Reduction Injectable drug with Patient Comfort in Focus
Aug. 11, 2025 /PRNewswire/ -- AMI Pharm, a biotechnology company focused on aesthetic and therapeutic innovations, announced today that its lead candidate, AYP-101, has entered a pivotal Phase
More news about: AMI Pharm